121 related articles for article (PubMed ID: 16429574)
1. An ex vivo approach for the evaluation of reversible inhibitors as potential pretreatments against organophosphate toxicity.
Tonduli LS; Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():426-7. PubMed ID: 16429574
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment with pyridostigmine bromide has no effect on seizure behavior or 24 hour survival in the rat model of acute diisopropylfluorophosphate intoxication.
Bruun DA; Guignet M; Harvey DJ; Lein PJ
Neurotoxicology; 2019 Jul; 73():81-84. PubMed ID: 30853371
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
Eckert S; Eyer P; Mückter H; Worek F
Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
[TBL] [Abstract][Full Text] [Related]
5. Subchronic administration of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity.
Lallement G; Foquin A; Dorandeu F; Baubichon D; Carpentier P
Drug Chem Toxicol; 2001 May; 24(2):165-80. PubMed ID: 11360433
[TBL] [Abstract][Full Text] [Related]
6. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
[TBL] [Abstract][Full Text] [Related]
7. The effect of pyridostigmine pretreatment on oxime efficacy against intoxication by soman or VX in rats.
Anderson DR; Harris LW; Woodard CL; Lennox WJ
Drug Chem Toxicol; 1992; 15(4):285-94. PubMed ID: 1459041
[TBL] [Abstract][Full Text] [Related]
8. The effect of ondansetron on pyridostigmine-induced blood acetylcholinesterase inhibition in the guinea pig.
Capacio BR; Byers CE; Anderson DR; Matthews RL; Brown DE
Drug Chem Toxicol; 1996; 19(1-2):1-19. PubMed ID: 8804550
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of reversible cholinesterase inhibitors (tacrine, pyridostigmine) and eqbuche against VX poisoning and brain acetylcholinesterase inhibition in rats.
Bajgar J
Acta Medica (Hradec Kralove); 2008; 51(4):223-8. PubMed ID: 19453088
[TBL] [Abstract][Full Text] [Related]
10. Effect of metoclopramide and ranitidine on the inhibition of human AChE by VX in vitro.
Bartling A; Thiermann H; Szinicz L; Worek F
J Appl Toxicol; 2005; 25(6):568-71. PubMed ID: 16167316
[TBL] [Abstract][Full Text] [Related]
11. Protection of human muscle acetylcholinesterase from soman by pyridostigmine bromide.
Maselli RA; Henderson JD; Ng J; Follette D; Graves G; Wilson BW
Muscle Nerve; 2011 Apr; 43(4):591-5. PubMed ID: 21404290
[TBL] [Abstract][Full Text] [Related]
12. Novel bifunctional hybrid small molecule scavengers for mitigating nerve agents toxicity.
Amitai G; Gez R; Raveh L; Bar-Ner N; Grauer E; Chapman S
Chem Biol Interact; 2016 Nov; 259(Pt B):187-204. PubMed ID: 27129421
[TBL] [Abstract][Full Text] [Related]
13. Cholinesterase reactivators and bioscavengers for pre- and post-exposure treatments of organophosphorus poisoning.
Masson P; Nachon F
J Neurochem; 2017 Aug; 142 Suppl 2():26-40. PubMed ID: 28542985
[TBL] [Abstract][Full Text] [Related]
14. Slow-binding reversible inhibitor of acetylcholinesterase with long-lasting action for prophylaxis of organophosphate poisoning.
Lenina OA; Zueva IV; Zobov VV; Semenov VE; Masson P; Petrov KA
Sci Rep; 2020 Oct; 10(1):16611. PubMed ID: 33024231
[TBL] [Abstract][Full Text] [Related]
15. Paraoxon and Pyridostigmine Interfere with Neural Stem Cell Differentiation.
Berríos VO; Boukli NM; Rodriguez JW; Negraes PD; Schwindt TT; Trujillo CA; Oliveira SL; Cubano LA; Ferchmin PA; Eterović VA; Ulrich H; Martins AH
Neurochem Res; 2015 Oct; 40(10):2091-101. PubMed ID: 25758980
[TBL] [Abstract][Full Text] [Related]
16. Subchronic administration of various pretreatments of nerve agent poisoning. I. Protection of blood and central cholinesterases, innocuousness towards blood-brain barrier permeability.
Lallement G; Foquin A; Dorandeu F; Baubichon D; Aubriot S; Carpentier P
Drug Chem Toxicol; 2001 May; 24(2):151-64. PubMed ID: 11360432
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholinesterase prophylaxis against organophosphate toxicity.
Wolfe AD; Rush RS; Doctor BP; Koplovitz I; Jones D
Fundam Appl Toxicol; 1987 Aug; 9(2):266-70. PubMed ID: 3653568
[TBL] [Abstract][Full Text] [Related]
18. Pyridostigmine bromide protection against acetylcholinesterase inhibition by pesticides.
Henderson JD; Glucksman G; Leong B; Tigyi A; Ankirskaia A; Siddique I; Lam H; DePeters E; Wilson BW
J Biochem Mol Toxicol; 2012 Jan; 26(1):31-4. PubMed ID: 21972196
[TBL] [Abstract][Full Text] [Related]
19. Chemical aspects of pharmacological prophylaxis against nerve agent poisoning.
Bajgar J; Fusek J; Kassa J; Kuca K; Jun D
Curr Med Chem; 2009; 16(23):2977-86. PubMed ID: 19689278
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors.
Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Kuča K; Petroianu GA
J Appl Toxicol; 2011 Aug; 31(6):515-23. PubMed ID: 20981864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
